FMT to Convert Response to Immunotherapy

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Melanoma Stage III · Melanoma Stage IV

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Antoni van Leeuwenhoek, Amsterdam, Netherlands
Contact: Study coordinator (Femke Burgers) · f.burgers@nki.nl · +31 20 512 9111

Study leads

John Haanen, Prof
Principal Investigator
Medical Oncologist

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

Melanoma Stage III · Melanoma Stage IV

Abroad (travel likely)RecruitingPHASE2

La Jolla, United States · San Francisco, United States

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Cancer · Melanoma Stage III · Melanoma Stage IV

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Rancho Santa Margarita, United States

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients

Melanoma Stage III · Melanoma Stage IV

Abroad (travel likely)RecruitingPHASE2

New York, United States

A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Louisville, United States